MDK and prostate carcinoma: Finally, to investigate whether GPC2 knockdown inhibited the malignancy of prostate cancer via MDK, we upregulated the expression of MDK in DU145 and PC-3 cells that were stably knocking down of GPC2, and performed functional assays.